Oili Kaipiainen-Seppänen Selected Research

Oili Kaipiainen-Seppänen Research Topics

9	Rheumatoid Arthritis 12/2021 - 04/2002
2	Arthritis (Polyarthritis) 12/2021 - 08/2015
2	Inflammation (Inflammations) 02/2020 - 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Joint Diseases (Joint Disease) 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2017
1	Necrosis 01/2017
1	Myalgia 01/2009
1	Fatigue 01/2009

5	Antirheumatic Agents (DMARD)IBA 01/2020 - 04/2002
4	Infliximab (Remicade)FDA Link 01/2020 - 06/2013
3	Pharmaceutical PreparationsIBA 02/2020 - 04/2002
3	Prednisolone (Predate)FDA LinkGeneric 11/2019 - 04/2002
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2013 - 04/2002
2	Methotrexate (Mexate)FDA LinkGeneric 06/2013 - 04/2002
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2013 - 04/2002
1	LeptinIBA 12/2021
1	AdiponectinIBA 12/2021
1	ResistinIBA 12/2021
1	AdipokinesIBA 12/2021
1	CholesterolIBA 12/2021
1	LipidsIBA 02/2020
1	AcetaldehydeIBA 02/2020
1	AntibodiesIBA 02/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	Lipoproteins (Lipoprotein)IBA 02/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2020
1	Malondialdehyde (Propanedial)IBA 02/2020
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	AntigensIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	ChitinasesIBA 01/2017
1	CollagenIBA 08/2015
1	homocitrullineIBA 08/2015
1	CitrullineIBA 08/2015
1	AutoantibodiesIBA 08/2015
1	Simvastatin (Zocor)FDA LinkGeneric 01/2009
1	EpitopesIBA 04/2002
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2002